Melcalin® Lupes

Melcalin Lupes is a food supplement made from fish oil and hop oil. Omega-3 fatty acids (EPA+DHA) contribute to the maintenance of normal cardiac function while the DHA helps to keep in good condition brain function and visual acuity. Hops promotes digestive function while vitamin E helps to protect cells from oxidative stress.

Indice
    Add a header to begin generating the table of contents

    Description

    Melcalin Lupes is a food supplement containing fish oil and hops; today’s diet leads to a large imbalance between the proportion of omega-6 and omega-3 entering, with a balance in favor of the former. Studies show that too high a value in omega 6 predispose to the risk of developing certain types of diseases (cardiovascular diseases, cancers, autoimmune diseases)10,11. That’s why Melcalin Lupes with its high content of omega-3 (over 80%) is a valuable aid to restore proper values of these essential fatty acids. The positive effects of Omega 3 fatty acids, whose protective action in the vascular system is known1,2,3,4,5,6,7,8,9 are associated to the effects of hop oil (product of Humulus lupulus.) whose active ingredients (flavonoids) provide relief from some symptoms associated with menopause such as hot flushes and irritability13,14,15,16,17 in addition to assisting the anti-inflammatory activity12,18 deriving from the presence of a high concentration of DHA.
    Vitamin E has an antioxidant and a support action.

    Fields of application

    • Cardiovascular Disorders and Pathologies
    • Disorders of menopause
    • Chronic inflammatory and autoimmune diseases
    • Functional psychological disorders
    • Neurodegenerative diseases

    Bibliography

    1. Fereidoon Shahidi. Oils: Sources, Applications, and Health Effects. Marine Nutraceuticals and Functional Foods, 2008.
    2. R.G. Ackman. Marine Lipids Omega-3 Fatty Acids. Handbook of Functional Lipids,2006.
    3. Bindels, FM Sohet, WJ Malaisse, M Francaux, YA Carpentier and NM Delzenne. Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition. BMC Physiol. 2008; 8: 21.  Published online 2008 December 1. doi: 10.1186/1472-6793- 8-21.
    4. B. Oelrich, A. Dewell, C.D. Gardner. Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults. Nutrition, Metabolism and Cardiovascular Diseases. In Press, Corrected Proof – Note to users.
    5. Emilio Ros, Juan C. Laguna. Tratamiento de la hipertrigliceridemia: fibratos frente a ácidos grasos omega-3 Treatment of Hypertriglyceridemia: Fibrates Versus Omega-3 Fatty Acids. Revista Española de Cardiología Suplementos Volume 6, Issue 4, 2006, Pages 52D-61D Utilidad terapéutica de los ácidos grasos omega-3.
    6. Chiara Martini, Valentina Pallottini, Elisabetta De Marinis, Maria Marino, Gabriella Cavallini, Alessio Donati, Sara Straniero, Anna Trentalance. Omega – 3 as well as caloric restriction prevent the agerelated modifications of cholesterol metabolism. Mechanisms of Ageing and Development Volume 129, Issue 12, December 2008, Pages 722-727.
    7. Vincentini O, Quaranta MG, Viora M, Agostoni C, Silano M. Docosahexaenoic acid modulates in vitro the inflammation of celiac disease in intestinal epithelial cells via the inhibition of cPLA2. Clin Nutr. 2011 Aug;30(4):541-6. Epub 2011 Mar 21.
    8. Narayan Bhaskar and K. Miyashita. Physiological Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)—A Review. 2007.
    9. Darshan S. Kelley, David Siegel, Dawn M. Fedor, Yuriko Adkins, and Bruce E.Mackey Supplementation Decreases Serum Creactive Protein and Other Markers of Inflammation in Hypertriglyceridemic Men.Journal of Nutrition published January 21, 2009, doi: 10.3945/ jn.108.100354.
    10. A.P Simopoulos. The importance of the ratio of omega-6/omega-3 essential acids. Biomedicine & Pharmacotherapy Volume 56, Issue 8, October 2002, Pages 365-379.
    11. A.P. Simopoulos. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomedicine & Pharmacotherapy Volume 60, Issue 9, November 2006, Pages 502-507.
    12. Veera R Konda, Anuradha Desai, Gary Darland, Jeffrey S Bland and Matthew L Tripp. Rho iso-alpha acids from hops inhibit the GSK-3/NF-B pathway reduce inflammatory markers associated with bone and cartilage degradation. Journal of Inflammation 2009, :26.
    13. Heyerick A, Vervarcke S, Depypere H, Bracke M, De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas. 2006 May 20;54(2):164-75.
    14. Overk CR, Yao P, Chadwick LR, Nikolic D, Sun Y, Cuendet MA, Deng Y, Hedayat AS, Pauli GF, Farnsworth NR, van Breemen RB, Bolton JL. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J Agric Food Chem. 2005 Aug 10;53(16):6246-53.
    15. Zanoli P, Zavatti M, Rivasi M, Brusiani F, Losi G, Puia G, Avallone R, Baraldi M. Evidence that the beta-acids fraction of hops reduces central GABAergic neurotransmission. J Ethnopharmacol. 2007 Jan 3;109(1):87-92. Epub 2006 Jul 11.
    16. H. Schiller, A. Forster, C. Vonhoff, M. Hegger, A. Biller, H. Winterhoff. Sedating effects of Humulus lupulus L. extracts. Phytomedicine Volume 13, Issue 8, 11 September 2006, Pages 535-541.
    17. P. Zanoli , , M. Zavatti, M. Rivasi, F. Brusiani, G. Losi, G. Puia, R. Avallone, M. Baraldi. Evidence that the -acids fraction of hops reduces central GABAergic neurotransmission. Journal of Ethnopharmacology Volume 109, Issue 1, 3 January 2007, Pages 87-92.
    18. Gerhauser C, Alt A, Heiss E, Gamal-Eldeen A, Klimo K, Knauft J, Neumann I, Scherf HR, Frank N, Bartsch H, Becker H. Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Mol Cancer Ther. 2002 Sep;1(11):959-69.

    Supplements with common fields of application

    Newsletter

    Enter your e-mail to keep up to date on Melcalin® products

    Newsletter

    Enter your e-mail to keep up to date on Melcalin® products

    melcalin-logo

    MELCALIN® IS A LINE OF FOOD SUPPLEMENTS SPECIFICALLY DESIGNED FOR THE RECOVERY OF THE ACID-BASE BALANCE, OF THE METABOLIC AND NEUROIMMUNOENDOCRINE FUNCTIONALITIES, FOR THE RECOVERY OF VAGA AND ASPECIFIC SYMPTOMS (MUS) AND THE ACHIEVEMENT OF PSYCHOYS

    melcalin-logo

    MELCALIN® IS A LINE OF FOOD SUPPLEMENTS SPECIFICALLY DESIGNED FOR THE RECOVERY OF THE ACID-BASE BALANCE, OF THE METABOLIC AND NEUROIMMUNOENDOCRINE FUNCTIONALITIES, FOR THE RECOVERY OF VAGA AND ASPECIFIC SYMPTOMS (MUS) AND THE ACHIEVEMENT OF PSYCHOYS

    PRODUCED BY BIOTEKNA © – BIOMEDICAL TECHNOLOGIES

    Melcalin® is a registered trademark of BioTekna © | Biomedical Technologies | VAT number 01307750933

    All rights reserved 1996 – 2022